Data / Form D filings / BIOTRICITY INC.
BIOTRICITY INC.: Form D filings
BIOTRICITY INC., a biotechnology company in Redwood City, CA, filed 6 Form D notices with the SEC between 2016 and 2024. The latest, on April 9, 2024, reports $1 million sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 203 REDWOOD SHORES PARKWAY, SUITE 600, Redwood City, CA, 94065
- Phone
- (650) 832-1626
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1630113
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | New notice | $1,000,000 | $1,000,000 | 1 | Mar 25, 2024 | sec.gov | |
| Aug 10, 2020 | New notice | $10,000,000 | $1,253,000 | $8,747,000 | 24 | Jul 14, 2020 | sec.gov |
| Dec 31, 2019 | New notice | $10,000,000 | $6,000,000 | $4,000,000 | 1 | Dec 19, 2019 | sec.gov |
| Mar 17, 2017 | New notice | $8,000,000 | $1,232,000 | $6,768,000 | 0 | Mar 7, 2017 | sec.gov |
| Aug 5, 2016 | Amendment | $2,500,000 | $1,150,000 | $1,350,000 | 4 | Mar 31, 2016 | sec.gov |
| Apr 18, 2016 | New notice | $1,000,000 | $525,000 | $475,000 | 4 | Mar 31, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chester A. White | Director | |
| David A. Rosa | Director | |
| John Ayanoglou | Executive Officer | |
| Waqaas Al-Siddiq | Executive Officer, Director | |
| Ronald A. McClurg | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 8, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BIOTRICITY INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.